NEW YORK (TheStreet) -- CHANGE IN RATINGSArcher-Daniels-Midland ADM was downgraded at BMO Capital. Valuation call, based on a $32 price target, BMO Capital said. Atmel ATML was downgraded at FBR Capital Markets from outperform to market perform. $7.50 price target. Company may lose market share in the near term, FBR Capital Markets said. AZZ AZZ was upgraded from neutral to buy at DA Davidson. Estimates were also boosted, as the recent acquisition should add to earnings. DA Davidson said. Chemtura CHMT was downgraded at Oppenheimer to perform from outperform. Approaching limits to further margin improvement, Oppenheimer said. Colgate-Palmolive CL was downgraded at Bank of America/Merrill Lynch from buy to neutral. $119 price target. Company is facing difficult comps and a currency headwind, BofA/Merrill Lynch said. CVR Refining CVRR was initiated with a neutral rating at Citigroup. $30 price target. Highly defensible position with modest upside, Citi said. CVR Refining LP was initiated with a buy rating at UBS. $31 price target. Yielding fruit of Midwest refining bonanza. Ford F was upgraded to buy at TheStreet Ratings. GM GM was upgraded to buy at TheStreet Ratings. Intel INTC was upgraded at Drexel Hamilton from sell to hold. $22 price target. Altera foundry deal should help future earnings, Drexel Hamilton said. LSI LSI was downgraded at FBR Capital Markets from outperform to market perform. $8 price target. Company is facing increased competition, FBR Capital Market said. Altria MO was downgraded at Bank of America/Merrill Lynch from buy to neutral. $36 price target. Company will likely face increased competition from RAI, BofA/Merrill Lynch said. Rosetta Resources ROSE was downgraded at Miller Tabak to sell. $41 price target. Company is running out of oil inventory, Miller Tabak said. Suntrust Banks STI was upgraded at FIG Partners to outperform. $32 price target. Expect positive results from the CCAR stress test, FIG Partners said.
STOCK COMMENTS / EPS CHANGESAutodesk ADSK estimates, price target were raised at Credit Suisse. Shares are now seen reaching $35. Estimates were also increased, as the company is signing more large deals, Credit Suisse said. Amgen AMGN estimates, target boosted at Guggenheim. Shares are now seen reaching $95. Estimates were also increased, as Epogen is facing less competition, following the Omontys recall, Guggenheim said. Neutral rating. Best Buy BBY price target was raised at UBS. Shares are now seen reaching $18. Prolonged stability is now needed to justify BBY's price move, UBS said. Neutral rating. Chuy's Holdings CHUY numbers were raised at Jefferies. Shares are now seen reaching $25. Estimates were also raised on unit growth. Hold rating. Capital One Financial COF numbers were lowered at Jefferies. Shares are now seen reaching $60. Estimates were also lowered on Best Buy card portfolio sale. Buy rating. Darden Restaurants DRI numbers were lowered at Oppenheimer. Shares are now seen reaching $51. Estimates were also lowered on uncertainty surrounding EPS growth, Oppenheimer said. Outperform rating. FirstEnergy FE numbers were cut at Credit Suisse. Shares are now seen reaching $46. Estimates were also reduced, as the company will likely issue more equity later this year, Credit Suisse said. Outperform rating. JM Smucker SJM numbers were increased at Keybanc. Estimates were raised through 2014. Company is focused on organic growth and improving efficiency, Keybanc said. Buy rating and new $100 price target. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.